The effect of esketamine in patients with treatment-resistant depression with and without comorbid anxiety symptoms or disorder.
Ella J DalyIbrahim TurkozGiacomo SalvadoreMaggie FedgchinDawn F IonescuH Lynn StarrStephane BorentainMadhukar H TrivediMichael E ThaseJaskaran B SinghPublished in: Depression and anxiety (2021)
Post hoc data support efficacy of esketamine plus an oral antidepressant in patients with TRD, regardless of comorbid anxiety.